NuvoMed
Signal active
Organization
Contact Information
Overview
NuvoMed offers a patented, disposable device called the DisImpactorTM, developed for the safe, fast, and effective relief of fecal impaction with maximum comfort and clinical efficacy. The company is committed to improving this unpleasant procedure for both the patient and physician. By significantly reducing the pain for the patient while providing a more capable tool for the physician, NuvoMed intends to provide the ultimate solution.
The company was founded in 2012 and is based in Seattle, Washington.
About
Industries
Health Care, Pharmaceutical, Medical Device
Founded
2012
Employees
1-10
Headquarters locations
Seattle, Washington, United States, North America
Social
Profile Resume
NuvoMed headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Medical Device sector. The company focuses on Health Care and has secured $51.3M in funding across 36 round(s). With a team of 1-10 employees, NuvoMed is actively contributing to advancements in Health Care. Their latest funding round, Venture Round - NuvoMed, raised $535.0K. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$1.4M
Details
2
NuvoMed has raised a total of $1.4M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2015 | Early Stage Venture | 500.0K | ||
| 2015 | Seed | 390.6K |
Investors
NuvoMed is funded by 5 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Marla Sanchez | - | FUNDING ROUND - Marla Sanchez | 500.0K |
| Jo Major | - | FUNDING ROUND - Jo Major | 500.0K |
| NuvoMed | - | FUNDING ROUND - NuvoMed | 500.0K |
| InSite Partners | - | FUNDING ROUND - InSite Partners | 500.0K |